RANDOMIZED TRIAL OF MEGESTROL-ACETATE VS MEGESTROL-ACETATE TAMOXIFEN FOR THE MANAGEMENT OF PROGRESSIVE OR RECURRENT EPITHELIAL OVARIAN-CARCINOMA

被引：27
作者：
BELINSON, JL [1 ]
MCCLURE, M [1 ]
BADGER, G [1 ]
机构：
[1] UNIV VERMONT,COLL MED,BIOMETRY FACIL,BURLINGTON,VT 05405
来源：
GYNECOLOGIC ONCOLOGY | 1987年 / 28卷 / 02期
关键词：
D O I：
10.1016/0090-8258(87)90208-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：151 / 155
页数：5
相关论文
共 17 条
[1]  
BELINSON JL, 1984, CANCER, V54, P1983, DOI 10.1002/1097-0142(19841101)54:9<1983::AID-CNCR2820540933>3.0.CO
[2]  
2-2
[3]  
BELINSON JL, IN PRESS GYNECOL ONC
[4]  
FORD LC, 1983, GYNECOL ONCOL, V115, P299
[5]  
GEISLER HE, 1983, OBSTET GYNECOL, V61, P95
[6]   PHASE-II TRIAL OF MEDROXYPROGESTERONE ACETATE IN ADVANCED OVARIAN-CANCER - AN EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP-STUDY [J].
HAMERLYNCK, JVTH ;
MASKENS, AP ;
MANGIONI, C ;
VANDERBURG, MEL ;
WILS, JAMJ ;
VERMORKEN, JB ;
ROTMENSZ, N .
GYNECOLOGIC ONCOLOGY, 1985, 22 (03) :313-316
[7]  
MALKASIAN GD, 1977, CANCER TREAT REP, V61, P913
[8]   HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED EPITHELIAL OVARIAN-CANCER RESISTANT TO 1ST-LINE OR 2ND-LINE CHEMOTHERAPY [J].
MANGIONI, C ;
FRANCESCHI, S ;
LAVECCHIA, C ;
DINCALCI, M .
GYNECOLOGIC ONCOLOGY, 1981, 12 (03) :314-318
[9]  
MANTEL N, 1966, CANCER CHEMOTHER REP, V50, P1963
[10]  
MYERS AM, 1981, CANCER, V48, P2368, DOI 10.1002/1097-0142(19811201)48:11<2368::AID-CNCR2820481105>3.0.CO
12